bg
N

Novocure (NVCR)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Novocure (NVCR)

NovoCure Limited is a commercial-stage oncology company. The Company is engaged in developing a cancer treatment centered on a therapy called TTFields, the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell divisi... Read more

  • USD14.65
  • USD15.42
  • USD14.31
  • USD83.60
  • -1.40%
  • 509M
  • 1.15M
  • 1.08M
  • 1.4B
  • 10.87
  • -78.30%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.